Stay updated on Ixazomib Combo in Relapsed Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Ixazomib Combo in Relapsed Multiple Myeloma Clinical Trial page.

Latest updates to the Ixazomib Combo in Relapsed Multiple Myeloma Clinical Trial page
- Check2 days agoChange DetectedThe history page now displays Revision: v3.4.3, replacing the previous Revision: v3.4.2.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedA new revision entry (v3.4.2) was added to the history, and an operating-status notice and an older revision (v3.4.1) were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check37 days agoChange DetectedA site-wide funding notice was added and the page revision tag updated to v3.4.1, while the previous revision v3.4.0 was removed. These changes do not modify the study record content or data; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check44 days agoChange DetectedThe history page now includes a glossary toggle and color-code legend (green for additions, red for deletions). It also shows the new revision note Revision: v3.4.0 and removes No FEAR Act data and Revision: v3.3.4.SummaryDifference0.9%

- Check58 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed in the page's history. This is a minor maintenance update and does not affect any study data or information presented on the page.SummaryDifference0.1%

- Check80 days agoChange DetectedThe Record History shows a minor system revision (Revision: v3.3.3) and removal of the HHS Vulnerability Disclosure link in the footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Ixazomib Combo in Relapsed Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ixazomib Combo in Relapsed Multiple Myeloma Clinical Trial page.